FDA Updates Class I Recall Alert For SynCardia's Bridge-To-Transplant System
SynCardia Systems' Freedom Driver System was subject to a class I recall last year, and now US FDA has updated its concerns about a component of the firm's Temporary Total Artificial Heart based on post-approval study data, and is asking that malfunctioning drivers be returned to the manufacturer.
You may also be interested in...
After years of setbacks, the company will launch its device in Europe as a bridge to transplant in heart failure patents.
Medtronic announced FDA's high-risk designation of recalls from its new subsidiary’s products on Sept. 30. HeartWare products have been subject to a total of nine class I recalls since 2013.
The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.